Antigenic domains of the open reading frame 2-encoded protein of hepatitis E virus

被引:43
作者
Khudyakov, YE
Lopareva, EN
Jue, DL
Crews, TK
Thyagarajan, SP
Fields, HA
机构
[1] US Dept HHS, Hepatitis Branch, Div Viral & Rickettsial Dis,Natl Ctr Infect Dis, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[2] US Dept HHS, Biotechnol Core Facil Branch, Sci Resources,Natl Ctr Infect Dis, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[3] Univ Madras, Dept Microbiol, Madras, Tamil Nadu, India
关键词
D O I
10.1128/JCM.37.9.2863-2871.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The antigenic composition of the hepatitis E virus (HEV) protein encoded by open reading frame 2 (ORF2) was determined by using synthetic peptides. Three sets of overlapping 18-, 25-, and 30-mer peptides, with each set spanning the entire ORF2 protein of the HEV Burma strain, were synthesized. All synthetic peptides were tested by enzyme immunoassay against a panel of 32 anti-HEV-positive serum specimens obtained from acutely HEV-infected persons. Six antigenic domains within the ORF2 protein were identified. Domains 1 and 6 located at the N and C termini of the ORF2 protein, respectively, contain strong immunoglobulin G (IgG) and IgM antigenic epitopes that can be efficiently modeled with peptides of different sizes. In contrast, antigenic epitopes identified within the two central domains (3 and 4) were modeled more efficiently with 30-mer peptides than with either 18- or 25-mers. Domain 2 located at amino acids (aa) 143 to 222 was modeled best with 25-mer peptides. A few 30-mer synthetic peptides derived from domain 5 identified at aa 490 to 579 demonstrated strong IgM antigenic reactivity. Several 30-mer synthetic peptides derived from domains 1, 4, and 6 immunoreacted with IgG or IgM with more than 70% of anti-HEV-positive serum specimens. Thus, the results of this study demonstrate the existence of six diagnostically relevant antigenic domains within the HEV ORF2 protein.
引用
收藏
页码:2863 / 2871
页数:9
相关论文
共 46 条
[1]   SEQUENCE AND GENE STRUCTURE OF THE HEPATITIS-E VIRUS ISOLATED FROM MYANMAR [J].
AYE, TT ;
UCHIDA, T ;
MA, XZ ;
IIDA, F ;
SHIKATA, T ;
ICHIKAWA, M ;
RIKIHISA, T ;
WIN, KM .
VIRUS GENES, 1993, 7 (01) :95-110
[2]   COMPLETE NUCLEOTIDE-SEQUENCE OF A HEPATITIS-E VIRUS ISOLATED FROM THE XINJIANG EPIDEMIC (1986-1988) OF CHINA [J].
AYE, TT ;
UCHIDA, T ;
MA, XZ ;
IIDA, F ;
SHIKATA, T ;
ZHUANG, H ;
WIN, KM .
NUCLEIC ACIDS RESEARCH, 1992, 20 (13) :3512-3512
[3]   SEQUENCE COMPARISON OF THE CAPSID REGION OF HEPATITIS-E VIRUSES ISOLATED FROM MYANMAR AND CHINA [J].
AYE, TT ;
UCHIDA, T ;
MA, XZ ;
IIDA, F ;
SHIKATA, T ;
ZHUANG, H ;
WIN, KM .
MICROBIOLOGY AND IMMUNOLOGY, 1992, 36 (06) :615-621
[4]  
BARANY G, 1980, PEPTIDES, V1, P1
[5]   THE SEQUENCE OF HEPATITIS-E VIRUS ISOLATED DIRECTLY FROM A SINGLE-SOURCE DURING AN OUTBREAK IN CHINA [J].
BI, SL ;
PURDY, MA ;
MCCAUSTLAND, KA ;
MARGOLIS, HS ;
BRADLEY, DW .
VIRUS RESEARCH, 1993, 28 (03) :233-247
[6]   ENTERICALLY-TRANSMITTED NON-A, NON-B HEPATITIS [J].
BRADLEY, DW .
BRITISH MEDICAL BULLETIN, 1990, 46 (02) :442-461
[7]  
BRADLEY DW, 1990, PROG MED VIROL, V37, P101
[8]   EXPRESSION OF HEPATITIS-E VIRUS PUTATIVE STRUCTURAL PROTEINS IN RECOMBINANT VACCINIA VIRUSES [J].
CARL, M ;
ISAACS, SN ;
KAUR, M ;
KE, JK ;
TAM, AW ;
YARBOUGH, PO ;
REYES, GR .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1994, 1 (02) :253-256
[9]  
COUSAGET P, 1993, FEMS MICROBIOL LETT, V109, P251
[10]   SOLID-PHASE ENZYME-LINKED-IMMUNOSORBENT-ASSAY FOR HEPATITIS-E VIRUS IGG AND IGM ANTIBODIES UTILIZING RECOMBINANT ANTIGENS AND SYNTHETIC PEPTIDES [J].
DAWSON, GJ ;
CHAU, KH ;
CABAL, CM ;
YARBOUGH, PO ;
REYES, GR ;
MUSHAHWAR, IK .
JOURNAL OF VIROLOGICAL METHODS, 1992, 38 (01) :175-186